We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Brain Tumors

News List

Treovir Announces Opening of G207 Phase 2 Clinical Trial in Children with Recurrent Brain Tumors Biotech Newswire
December 05, 2024
Treovir, Inc. announced today the opening of a Phase 2 trial testing G207, an oncolytic HSV immunotherapy, in pediatric brain tumor patients.
Targeted drug combination shows unprecedented activity in some highly aggressive brain tumors WorldPharmaNews
November 26, 2021
A combination of two targeted cancer drugs showed unprecedented, "clinically meaningful" activity in patients with highly malignant brain tumors that carried a rare genetic mutation...
NaviFUS begins FUS combined with radiotherapy clinical trial for the treatment of terminal primary brain tumors prnasia
August 04, 2021
NaviFUS' focused ultrasound (FUS) therapy system (NaviFUS®) was recently approved for use in a new clinical trial by the Taiwan, China Food and Drug Administration (TFDA).
The Mikey Czech Foundation Contributes $1 Million To DIPG Research At Dana-Farber Cancer Institute en-cphi.cn
March 30, 2017
The Mikey Czech Foundation, Inc. announced a $1,000,000 gift to Pediatric Medical Neuro-Oncology at Dana-Farber, headed by Mark W. Kieran, MD, PhD, and located in Boston, Massachusetts.